Articles
Hypertension
h 
Home self blood pressure measurement in general practice: the SMART
study
(Jul 96 AJH)
h
Effects of calcium entry blockers on distribution blood volume
(Jul 96 AJH)
h
Grapefruit juice increases antihypertensive effect of calcium
channel blockers
(Jul 96 AFM)
h
Dispersion of the QT interval and autonomic modulation of heart rate
in hypertensive men with and without left ventricular hypertrophy
(Jul 96 HYP)
h
High sodium sensitivity implicates nocturnal hypertension in
essential hypertension
(Jul 96 HYP)
h
Calcium antagonists and mortality in patients with coronary artery
disease: A cohort study of 11,575 patients
(Jul 96 JACC)
h
Screening for mild thyroid failure at the periodic health examination
(Jul 96 JAMA)
h
Sudden death in young competitive athletes
(Jul 96 JAMA)
h 
Effects of sodium intake on albumin excretion in patients with
diabetic nephropathy treated with long acting calcium
antagonists
(Aug 96 AIM)
h
The urinary metanephrine-to-creatinine ratio for the diagnosis of
pheochromocytoma
(Aug 96 AIM)
h
Prevalence and risk factors in spontaneous intracerebral
hemorrhage and aneurysmal subarachnoid hemorrhage
(Aug 96 AN)
h
Prospective study of oral contraceptives and hypertension among women
in the United States
(Aug 96 CIRC)
h
Influence of ACE and Angiotensin II type 1 receptor gene
polymorphisms on aortic stiffness in normotensive and hypertensive
patients
(Aug 96 CIRC)
h
Association between persistent pressure overload and ventricular
arrhythmias in essential hypertension
(Aug 96 HYP)
h
Elevated plasma lipoprotein(a) and coronary heart disease in men aged
55 years and younger
(Aug 96 JAMA)
h
An inhibitor of the sodium pump obtained from human placenta
(Aug 96 LANCET)
h
Calcium channel blockade and the incidence of cancer in aged
populations
(Aug 96 LANCET)
h
Overall stroke risk and combined oral contraceptives: results
of an international, multicentre, case-control study
(Aug 96 LANCET)
h 
Long-term renal preservation in essential hypertension: angiotensin
converting enzyme inhibition is superior to beta-blockade
(Sep 96 AJH)
h
Hypertension-associated hypalgesia: Evidence in experimental animals
and humans, pathophysiological mechanisms, and potential clinical
consequences
(Sep 96 HYP)
h
Final outcome results of the multicenter isradipine diuretic
atherosclerosis study (MIDAS): A randomized controlled trial
(Sep 96 JAMA)
h
White-coat hypertension as a cause of cardiovascular dysfunction
(Sep 96 LANCET)
h
Pregnancy and the risk of stroke
(Sep 96 NEJM)
h
Occult lead intoxication as a cause of hypertension and renal failure
(Sep 96 NDT)
Dialysis, Chronic Renal Failure
d
The site of injection affects erythropoietin levels during dialysis
(Jul 96 ASAIOJ)
d
Midodrine efficacy and pharmacokinetics in a patient with recurrent
intradialytic hypotension
(Jul 96 AJKD)
d
The impact of anemia on cardiomyopathy, morbidity, and
mortality in ESRD
(Jul 96 AJKD)
d
Fungal peritonitis in a large chronic peritoneal dialysis population:
A report of 55 episodes
(Jul 96 AJKD)
d
Heparin-induced thrombocytopenia in dialysis patients
(Jul 96 AJKD)
d
Vascular dysfunction in monkeys with diet-induced hyperhomocysteinemia
(Jul 96 JCI)
d
Effects of recombinant human growth hormone on plasma and dialysate
amino acid profiles in CAPD patients
(Jul 96 KI)
d
Serum albumin in continuous peritoneal dialysis: Its predictors and
relationship to urea clearance
(Jul 96 KI)
d
Reproducibility of studies of peritoneal dialysis adequacy
(Jul 96 KI)
d
Long term effects of renal transplantation on dialysis-related
amyloid deposits and symptomatology
(Jul 96 KI)
d
Supervised intradialytic oral iron administration during
erythropoietin therapy
(Jul 96 NDT)
d
Outcome of pregnancy in women with moderate or severe renal
insufficiency
(Jul 96 NEJM)
d
Small peptides as potent mimetics of the protein hormone
erythropoietin
(Jul 96 SCI)
d
Role of volume overload in dialysis-refractory hypertension
(Aug 96 AJKD)
d
Effect of dialyzer reuse on survival of patients treated with
hemodialysis
(Aug 96 JAMA)
d
ACTH lowers serum lipids in steroid-treated hyperlipemic patients with
kidney disease
(Aug 96 KI)
d
Effect of the dialysis membrane on mortality of chronic
hemodialysis patients
(Aug 96 KI)
d
The dose of hemodialysis and mortality
(Aug 96 KI)
d
Dysregulation of melatonin metabolism in chronic renal insufficiency:
Role of erythropoietin induced anemia
(Aug 96 KI)
d
Sterile peritonitis outbreaks among peritoneal dialysis patients
associated with possibly contaminated commercial dialysate. New York.
(Aug 96 NYHD)
d
High-normal calcium (1.35 mmol/l) dialysate in patients on CAPD:
eficient and safe long-term control of plasma calcium, phosphate, and
parathyroid hormone
(Aug 96 NDT)
d
The equivalent renal clearance: a new parameter to assess dialysis
dose
(Aug 96 NDT)
d
Response to the hepatitis B virus vaccine in haemodialysis patients:
influence of malnutrition and its importance as a risk factor for
morbidity and mortality
(Aug 96 NDT)
d
Protein nitrogen appearance in CAPD patients: what is the best
formula?
(Aug 96 NDT)
d
Association between prior cytomegalovirus infection and the risk of
restenosis after coronary atherectomy
(Aug 96 NEJM)
d
Pharmacokinetics of once-daily IP gentamicin in CAPD patients
(Aug 96 PDI)
d
Hemodynamic effects of peritoneovenous shunts in hemodialysis patients
with ascites
(Sep 96 AJKD)
d
Proximal calciphylaxis in four insulin-requiring diabetic
dialysis patients
(Sep 96 AJKD)
d
Silastic cuffed catheters for hemodialysis vascular access:
Thrombolytic and mechanical correction of malfunction
(Sep 96 AJKD)
d
Restless leg syndrome in end-stage renal disease
(Sep 96 AJKD)
d
Hemolysis in membrane plasma separators: is it caused by filter
or user?
(Sep 96 AO)
d
Bullous dermatosis of end-stage renal disease: a posible association
between abnormal porphyrin metabolism and aluminum
(Sep 96 NDT)
d
A dialysis patient with unexplained peripheral neuropathy
(Sep 96 NDT)
d
Safety of intravenous injection of iron saccharate in haemodialysis
patients
(Sep 96 NDT)
Clinical Nephrology
c
Recurrence of IgA nephropathy after renal transplantation in
the cyclosporine era
(Jul 96 AJKD)
c
Timing of complications in percutaneous renal biopsy: What is
the optimal period of observation?
(Jul 96 AJKD)
c
Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of
relapses in Wegener's Granulomatosis
(Jul 96 NEJM)
c
GBM thickness -- a comparison of two methods of measurement in
patients with unexplained haematuria
(Jul 96 NDT)
c
Is cholesterol embolic disease an unrecognized cause of renal graft
dysfunction?
(Jul 96 NDT)
c
Treatment of anemia of nephrotic syndrome with recombinant
erythropoietin
(Aug 96 AJKD)
c
Dietary and behavioral risk factors for urolithiasis: potential
implications for prevention
(Aug 96 AJKD)
c
Cyclosporin A impairs the nocturnal blood pressure fall in
renal transplant recipients
(Aug 96 HYP)
c
Diuretic efficacy of high dose furosemide in severe heart
failure: bolus injection versus continuous infusion
(Aug 96 JACC)
c
Reversible membranous nephropathy associated with the use of
nonsteroidal anti-inflammatory drugs
(Aug 96 JAMA)
c
Phase 1 study of subcutaneously administered interleukin-2 in combination
with interferon alfa-2a in patients with advanced cancer
(Aug 96 JCO)
c
Angiotensin I converting enzyme gene polymorphism in non-insulin
dependent diabetes mellitus
(Aug 96 KI)
c
Brief Report: Hemolytic uremic syndrome in a six-year-old girl with a
urinary tract infection with shiga-toxin-producing E. coli
O103:H2
(Aug 96 NEJM)
c
Treatment of nephrotic syndrome with a supplemented low-protein
diet
(Sep 96 AJKD)
c
Methylprednisolone and cyclophosphamide, alone or in combination, in patients
with lupus nephritis: a randomized, controlled trial
(Sep 96 AIM)
c
Nephrology Forum: The renal allograft biopsy
(Sep 96 KI)
c
Association between specific HLA combinations and probability of
kidney allograft loss: the taboo concept
(Sep 96 LANCET)
c
Randomised controlled trial of steroid withdrawal in renal
transplant recipients receiving triple immunosuppression
(Sep 96 LANCET)
c
Renal transplantation in adults with thrombotic thrombocytopenic
purpura - haemolytic-uraemic syndrome
(Sep 96 NDT)
c
Beware of dog! A syndrome resembling thrombotic thrombocytopenic
purpura associated with Capnocytophaga canimorsus septicemia
(Sep 96 NDT)
c
Drug-interaction-induced rhabdomyolysis
(Sep 96 NDT)
c
A multicenter trial of FK506 (tacrolimus) therapy in refractory
acute renal allograft rejection: A report of the tacrolimus kidney
transplantation rescue group
(Sep 96 TRAN)
Use back arrow on your browser to go back to HDCN home page (faster)
or click on the arrow.